UMEM Educational Pearls

Title: Ceftaroline, a fifth generation cephalosporin

Category: Pharmacology & Therapeutics

Keywords: MRSA, antibiotic, pneumonia, CAP, cephalosporin, infection (PubMed Search)

Posted: 1/5/2012 by Ellen Lemkin, MD, PharmD
Click here to contact Ellen Lemkin, MD, PharmD

 

  • Approved for CAP and Skin/Skin structure infections
  • “Fifth generationcephalosporin- implies activity against MRSA, although has broad spectrum
  • Resistance is expected to be limited, with the exception of VRE, and VSE (vanco resistant or sensitive enterococcus faecalis)

  • Renally excreted

  • Common side effects: diarrhea, nausea, headache

  • Serious side effects: anaphylaxis, renal failure, hepatitis, seizure

  • Low incidence of C. difficile

  • Dose : 600 mg IV (over 1 hour) q12 hours X 5-7 days